We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
While some drug price hikes in the hundreds or thousands of percentages appear to be purely about profit and generate plenty of criticism, a new paper in the Journal of the National Cancer Institute highlights another lucrative strategy for drugmakers tha